Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00GLQ
|
||||
Former ID |
DIB001622
|
||||
Drug Name |
2LM20-4
|
||||
Synonyms |
Anti-CD20 SMIP (autoimmune disease), Pfizer; Anti-CD20 small modular immunopharmaceutical (autoimmune disease), Pfizer
|
||||
Indication | Autoimmune diabetes [ICD10:E08-E13] | Investigative | [543668] | ||
Company |
Pfizer Inc
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD20 | Target Info | Modulator | [543668] | |
KEGG Pathway | Hematopoietic cell lineage | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.